Free Trial

Immuron (IMRN) News Today

Immuron logo
$0.79 -0.02 (-2.08%)
Closing price 05/5/2026 04:00 PM Eastern
Extended Trading
$0.79 0.00 (0.00%)
As of 05/5/2026 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IMRN Latest News

Immuron Ltd. ADR
Immuron Double Digit 3Q Sales Growth
Immuron Reports HY26 Results and Strategic Reset
Immuron Reports Continued Sales Growth
Immuron New U.S. Department of Defense Award & Clinical Trial Update
Immuron IMM-529 IND approved by FDA
Immuron Limited: Immuron Announces Clinical Trial Update
Immuron Announces Clinical Trial Update
Immuron Q1 FY26 YoY growth
Immuron Submits IMM-529 IND to FDA
Immuron Letter to Shareholders – Projects Update
Immuron enters partnership with InvestorHub
Immuron partners with InvestorHub
Immuron Letter to Shareholders: Projects Update
Immuron reports record Travelan sales
Immuron Limited Announces New Share Issuance
Immuron Limited Announces New Securities Issuance
Immuron Travelan® highest sales in history
Get Immuron News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMRN and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IMRN Media Mentions By Week

IMRN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMRN
News Sentiment

-0.20

0.56

Average
Medical
News Sentiment

IMRN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMRN Articles
This Week

1

1

IMRN Articles
Average Week

Get the Latest News and Ratings for IMRN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Immuron and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:IMRN) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners